Pyruvate sensitizes pancreatic tumors to a hypoxia activated pro-drug TH-302.

J. W. Wojtkowiak, H. C. Cornell, S. Matsumoto, K. Saito, Y. Takakusagi, P. Dutta, M. Kim, X. Zhang, R. Leo, K. M. Bailey, G. Martinez, M. C. Lloyd, R. M. Lynch, A. Baker, R. A. Gatenby, K. Rejniak, C. Hart, M. C. Krishna, R. J. Gillies

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2-15
JournalCancer Metab.
Volume3
DOIs
StatePublished - Jan 29 2015

Cite this